Indication
Anemia in hemodialysis-dependent chronic kidney disease
Anemia in hemodialysis-dependent chronic kidney disease is a severe hematologic complication affecting patients with end-stage kidney disease who require maintenance hemodialysis. Read more about Anemia in hemodialysis-dependent chronic kidney disease
22 drugs 19 manufacturers
Drugs that treat it
Common Anemia in hemodialysis-dependent chronic kidney disease therapies.
VAFSEO (vadadustat)
SOD FERRIC GLUCONATE COMPLEX (sodium ferric gluconate complex in sucrose)
SOD FERRIC GLUCONATE COMPLEX (sodium ferric gluconate complex in sucrose)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnemia in hemodialysis-dependent chronic kidney disease is a severe hematologic complication affecting patients with end-stage kidney disease who require maintenance hemodialysis.
It is characterized by impaired erythropoiesis leading to abnormally low circulating red blood cell mass and hemoglobin concentrations.
The pathophysiology is multifactorial, driven primarily by a relative deficiency in renal erythropoietin production alongside systemic and functional iron deficiency from chronic inflammation, elevated hepcidin levels, frequent procedural blood loss, and shortened red blood cell survival.
Clinically, this state results in reduced tissue oxygen delivery, exacerbating cardiovascular strain, chronic fatigue, and overall morbidity in the dialysis population.
- nih.gov
Anemia in hemodialysis-dependent chronic kidney disease is a severe hematologic complication affecting patients with end-stage kidney disease who require maintenance hemodialysis The pathophysiology is multifactorial, driven primarily by a relative deficiency in renal erythropoietin production alongside systemic and functional iron deficiency from chronic inflammation, elevated hepcidin levels, frequent procedural blood loss, and shortened red blood cell survival
- nih.gov
Anemia in hemodialysis-dependent chronic kidney disease is a severe hematologic complication affecting patients with end-stage kidney disease who require maintenance hemodialysis It is characterized by impaired erythropoiesis leading to abnormally low circulating red blood cell mass and hemoglobin concentrations
- nih.gov
It is characterized by impaired erythropoiesis leading to abnormally low circulating red blood cell mass and hemoglobin concentrations Clinically, this state results in reduced tissue oxygen delivery, exacerbating cardiovascular strain, chronic fatigue, and overall morbidity in the dialysis population
- nih.gov
The pathophysiology is multifactorial, driven primarily by a relative deficiency in renal erythropoietin production alongside systemic and functional iron deficiency from chronic inflammation, elevated hepcidin levels, frequent procedural blood loss, and shortened red blood cell survival
- nih.gov
Clinically, this state results in reduced tissue oxygen delivery, exacerbating cardiovascular strain, chronic fatigue, and overall morbidity in the dialysis population
Personalize your experience
Follow Anemia in hemodialysis-dependent chronic kidney disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.